NL191789C - Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen. - Google Patents
Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen.Info
- Publication number
- NL191789C NL191789C NL8002997A NL8002997A NL191789C NL 191789 C NL191789 C NL 191789C NL 8002997 A NL8002997 A NL 8002997A NL 8002997 A NL8002997 A NL 8002997A NL 191789 C NL191789 C NL 191789C
- Authority
- NL
- Netherlands
- Prior art keywords
- acetylaminoalkanesulfonic
- acid derivatives
- pharmacological properties
- pharmacological
- properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7913207A FR2457281A1 (fr) | 1979-05-23 | 1979-05-23 | Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee |
FR7913207 | 1979-05-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8002997A NL8002997A (nl) | 1980-11-25 |
NL191789B NL191789B (nl) | 1996-04-01 |
NL191789C true NL191789C (nl) | 1996-08-02 |
Family
ID=9225819
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8002997A NL191789C (nl) | 1979-05-23 | 1980-05-23 | Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen. |
NL970003C NL970003I2 (nl) | 1979-05-23 | 1997-01-22 | Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL970003C NL970003I2 (nl) | 1979-05-23 | 1997-01-22 | Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4355043A (nl) |
JP (2) | JPS5625146A (nl) |
AT (1) | AT372371B (nl) |
AU (1) | AU535785B2 (nl) |
BE (1) | BE883468A (nl) |
CA (1) | CA1152100A (nl) |
CH (1) | CH647757A5 (nl) |
DE (2) | DE3019350A1 (nl) |
ES (1) | ES491787A0 (nl) |
FR (1) | FR2457281A1 (nl) |
GB (1) | GB2051789B (nl) |
GR (1) | GR68547B (nl) |
IT (1) | IT1130455B (nl) |
MA (1) | MA18855A1 (nl) |
MX (1) | MX9203363A (nl) |
NL (2) | NL191789C (nl) |
OA (1) | OA06606A (nl) |
ZA (1) | ZA803051B (nl) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU193197B (en) * | 1984-02-03 | 1987-08-28 | Egyt Gyogyszervegyeszeti Gyar | Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent |
JPH0725771B2 (ja) * | 1992-06-18 | 1995-03-22 | 財団法人生産開発科学研究所 | 2−アミノエタンスルホン酸亜鉛錯化合物 |
US20040208875A1 (en) * | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
AU703540B2 (en) * | 1996-03-26 | 1999-03-25 | Meddiss, Incorporated | Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
US6057373A (en) * | 1997-05-22 | 2000-05-02 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists |
US5952389A (en) * | 1998-01-13 | 1999-09-14 | Synchroneuron | Methods of treating tardive dyskinesia and other movement disorders |
US6294583B1 (en) * | 1998-01-13 | 2001-09-25 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders |
US6391922B1 (en) | 1998-01-13 | 2002-05-21 | Synchroneuron, Llc | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
AU765522B2 (en) * | 1998-01-13 | 2003-09-18 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders |
PT1051393E (pt) * | 1998-01-27 | 2004-02-27 | Merck Sante Sas | Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos |
US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
ATE441421T1 (de) * | 1999-04-28 | 2009-09-15 | Bellus Health Int Ltd | Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten |
US6562836B1 (en) | 1999-05-24 | 2003-05-13 | Queen's University Of Kingston | Methods and compounds for inhibiting amyloid deposits |
US7414076B2 (en) * | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
CA2586111A1 (en) * | 2004-11-12 | 2006-06-08 | Neurochem (International) Limited | Methods and fluorinated compositions for treating amyloid-related diseases |
CA2586334A1 (en) * | 2004-11-16 | 2006-06-08 | Neurochem (International) Limited | Compounds for the treatment of cns and amyloid associated diseases |
EP1836161B1 (en) | 2004-12-22 | 2016-07-20 | BHI Limited Partnership | Methods and compositions for treating amyloid-related diseases |
TW200716088A (en) * | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
CA2634871A1 (en) * | 2005-12-22 | 2007-11-08 | Neurochem (International) Limited | Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
AU2007357451B2 (en) | 2006-10-12 | 2012-11-15 | Bhi Limited Partnership. | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
MX2009006768A (es) * | 2006-12-22 | 2009-08-31 | Bellus Health Int Ltd | Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes. |
KR100877134B1 (ko) * | 2007-05-03 | 2009-01-09 | 주식회사 엔지켐 | 아캄프로세이트 칼슘의 제조방법 |
TW200924748A (en) * | 2007-09-07 | 2009-06-16 | Xenoport Inc | Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
WO2009033079A1 (en) * | 2007-09-07 | 2009-03-12 | Xenoport, Inc. | Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
TW200932734A (en) * | 2007-10-15 | 2009-08-01 | Xenoport Inc | Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
CN101492400B (zh) * | 2008-01-22 | 2014-03-12 | 北京华禧联合科技发展有限公司 | 一种高纯度阿坎酸钙的制备方法 |
DE102008048791A1 (de) * | 2008-09-24 | 2010-03-25 | Merck Patent Gmbh | Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat |
IT1392327B1 (it) * | 2008-09-26 | 2012-02-28 | Laboratorio Chimico Int Spa | Nuova forma polimorfa del calcio acamprosato |
CN104478766A (zh) * | 2014-12-25 | 2015-04-01 | 北京华禧联合科技发展有限公司 | 一种制备高纯度乙酰基高牛磺酸的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3039916A (en) * | 1961-03-27 | 1962-06-19 | West Laboratories Inc | Anionic iodine complexes |
US3544597A (en) * | 1969-06-12 | 1970-12-01 | Rohm & Haas | Process for manufacturing sulfonated amides |
JPS5418714B2 (nl) * | 1974-10-08 | 1979-07-10 | ||
FR2321285A1 (fr) * | 1975-08-18 | 1977-03-18 | Stanley Drug Products Inc | Agents antifibrinolytiques |
FR2384751A1 (fr) * | 1977-03-23 | 1978-10-20 | Francaise Coop Pharma | Nouveaux derives de la taurine a activite neuro-musculaire renforcee |
US4233229A (en) * | 1978-01-03 | 1980-11-11 | Gaf Corporation | Preparation of salt-free N-acyl taurines |
-
1979
- 1979-05-23 FR FR7913207A patent/FR2457281A1/fr active Granted
-
1980
- 1980-05-19 US US06/150,946 patent/US4355043A/en not_active Expired - Lifetime
- 1980-05-20 GR GR62000A patent/GR68547B/el unknown
- 1980-05-21 DE DE19803019350 patent/DE3019350A1/de active Granted
- 1980-05-21 DE DE1996175017 patent/DE19675017I2/de active Active
- 1980-05-22 GB GB8016956A patent/GB2051789B/en not_active Expired
- 1980-05-22 MA MA19051A patent/MA18855A1/fr unknown
- 1980-05-22 AT AT0274580A patent/AT372371B/de not_active IP Right Cessation
- 1980-05-22 CH CH3998/80A patent/CH647757A5/fr not_active IP Right Cessation
- 1980-05-22 IT IT67807/80A patent/IT1130455B/it active
- 1980-05-22 ZA ZA00803051A patent/ZA803051B/xx unknown
- 1980-05-23 ES ES491787A patent/ES491787A0/es active Granted
- 1980-05-23 OA OA57119A patent/OA06606A/xx unknown
- 1980-05-23 BE BE0/200755A patent/BE883468A/fr not_active IP Right Cessation
- 1980-05-23 JP JP6796380A patent/JPS5625146A/ja active Granted
- 1980-05-23 NL NL8002997A patent/NL191789C/nl not_active IP Right Cessation
- 1980-05-23 CA CA000352613A patent/CA1152100A/en not_active Expired
- 1980-05-23 AU AU58697/80A patent/AU535785B2/en not_active Expired
-
1990
- 1990-10-17 JP JP2276598A patent/JPH03148219A/ja active Granted
-
1992
- 1992-06-25 MX MX9203363A patent/MX9203363A/es unknown
-
1997
- 1997-01-22 NL NL970003C patent/NL970003I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DE19675017I2 (de) | 2001-04-26 |
ES8101042A1 (es) | 1980-12-16 |
JPS5625146A (en) | 1981-03-10 |
FR2457281A1 (fr) | 1980-12-19 |
ZA803051B (en) | 1981-06-24 |
DE3019350A1 (de) | 1980-12-04 |
NL970003I1 (nl) | 1997-04-01 |
GR68547B (nl) | 1982-01-18 |
GB2051789A (en) | 1981-01-21 |
JPH03148219A (ja) | 1991-06-25 |
IT8067807A0 (it) | 1980-05-22 |
DE3019350C2 (nl) | 1989-11-30 |
CA1152100A (en) | 1983-08-16 |
NL970003I2 (nl) | 1997-08-01 |
AU535785B2 (en) | 1984-04-05 |
JPH0524135B2 (nl) | 1993-04-06 |
JPH0317825B2 (nl) | 1991-03-11 |
NL191789B (nl) | 1996-04-01 |
US4355043A (en) | 1982-10-19 |
FR2457281B1 (nl) | 1983-10-07 |
IT1130455B (it) | 1986-06-11 |
AU5869780A (en) | 1980-11-27 |
ES491787A0 (es) | 1980-12-16 |
MA18855A1 (fr) | 1980-12-31 |
ATA274580A (de) | 1983-02-15 |
AT372371B (de) | 1983-09-26 |
OA06606A (fr) | 1981-08-31 |
GB2051789B (en) | 1983-04-27 |
MX9203363A (es) | 1992-07-01 |
BE883468A (fr) | 1980-11-24 |
CH647757A5 (fr) | 1985-02-15 |
NL8002997A (nl) | 1980-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL191789C (nl) | Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen. | |
DK343980A (da) | 2,4,6-triiod-isophthalsyrederivater | |
DK343880A (da) | 2,4,6-triiod-isophthalsyrederivater | |
NO791140L (no) | Tioetiansyrederivater. | |
ATE24320T1 (de) | Azabicyclo-alkyl-derivate. | |
NO802946L (no) | Imidazo-diazepinderivater | |
IT8024915A0 (it) | Soluzioni. | |
NO801274L (no) | Fjernvarmeroer. | |
NO163436C (no) | Serum-separasjonsroer. | |
KR840004668A (ko) | 5-펜타노익산류 | |
NL7712750A (nl) | 1-carba-2-penem-3-carbonzuur en derivaten. | |
NL7704210A (nl) | Fenoxy-fenoxypropionzuurderivaten. | |
IT7928239A0 (it) | Termocapsula con microsoffietto. | |
SE7806711L (sv) | 7alfa-metoxi-7beta-(1,3-ditietan-2-karboxamido)-cefalosporansyraderivat | |
NL191740C (nl) | Loopplank. | |
SE8002708L (sv) | Penem-3-karboxisyraderivat | |
NL7704174A (nl) | Nieuwe m-fenylfenoxypropionzuurderivaten en de bereidingswijze daarvan. | |
NO803592L (no) | 4,5-umettede prostansyre-derivater. | |
DK394177A (da) | 7-acylamino-8-oxo-3-oxa-1-azabicyklo-(4.2.0)-octan-2-carboxylsyrederivater | |
NL7805747A (nl) | Zuur alkalicitraat. | |
DK501880A (da) | Cyclopropancarboxylsyreesterderivater | |
DK446482A (da) | 1-acyloxy-24,24-difluor-25-hydroxy-cholestan-5,7-diener | |
NO802888L (no) | 2-klor-4,5-disubstituerte-thiazoler | |
NO802172L (no) | Substituerte difenyletere. | |
NL7705896A (nl) | Polyprenylcarbonzuurderivaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AC1 | Application for a supplementary protection certificate |
Free format text: 970003, 970122 |
|
KC1 | Grant of a supplementary protection certificate |
Free format text: 970003, 20000523, EXPIRES: 20050522 |
|
SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: LIPHA |
|
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 20000523 |